JP2003505383A - 新規ジフェニル−ピペリジン誘導体 - Google Patents
新規ジフェニル−ピペリジン誘導体Info
- Publication number
- JP2003505383A JP2003505383A JP2001511441A JP2001511441A JP2003505383A JP 2003505383 A JP2003505383 A JP 2003505383A JP 2001511441 A JP2001511441 A JP 2001511441A JP 2001511441 A JP2001511441 A JP 2001511441A JP 2003505383 A JP2003505383 A JP 2003505383A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- piperidinyl
- diphenyl
- chlorobenzyl
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902765A SE9902765D0 (sv) | 1999-07-21 | 1999-07-21 | Novel compounds |
| SE9902765-8 | 1999-07-21 | ||
| PCT/GB2000/002756 WO2001005782A1 (en) | 1999-07-21 | 2000-07-18 | Novel diphenyl-piperidine derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003505383A true JP2003505383A (ja) | 2003-02-12 |
| JP2003505383A5 JP2003505383A5 (cg-RX-API-DMAC10.html) | 2007-08-16 |
Family
ID=20416552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001511441A Withdrawn JP2003505383A (ja) | 1999-07-21 | 2000-07-18 | 新規ジフェニル−ピペリジン誘導体 |
Country Status (17)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531835A (ja) * | 2007-07-02 | 2010-09-30 | エフ.ホフマン−ラ ロシュ アーゲー | Ccr2受容体アンタゴニストとしてのイミダゾール誘導体 |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200303304A (en) * | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
| SE0400208D0 (sv) | 2004-02-02 | 2004-02-02 | Astrazeneca Ab | Chemical compounds |
| EP1962605A2 (en) * | 2005-12-12 | 2008-09-03 | Merck & Co., Inc. | 2-arylthiazole derivatives as cxcr3 receptor modulators |
| US10344095B2 (en) * | 2006-02-16 | 2019-07-09 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
| TW200812582A (en) * | 2006-04-06 | 2008-03-16 | Astrazeneca Ab | Medicaments |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| US8778616B2 (en) | 2009-05-26 | 2014-07-15 | University Of Kentucky Research Foundation | Method of using CCR3 binding agents to detect choroidal neovascularization |
| US9394258B2 (en) | 2013-03-14 | 2016-07-19 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2014153172A1 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| CA2903394C (en) | 2013-03-14 | 2021-08-31 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| EP2970135B1 (en) | 2013-03-14 | 2018-07-18 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9133189B2 (en) | 2013-03-14 | 2015-09-15 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US20160039767A1 (en) | 2013-03-14 | 2016-02-11 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| EP2970181B1 (en) | 2013-03-14 | 2017-06-07 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| EP3363434A1 (en) | 2013-03-14 | 2018-08-22 | Epizyme Inc | Arginine methyltransferase inhibitors and uses thereof |
| JP2016514164A (ja) | 2013-03-14 | 2016-05-19 | エピザイム,インコーポレイティド | アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用 |
| PT3022202T (pt) | 2013-07-18 | 2019-09-03 | Novartis Ag | Inibidores da autotaxina compreendendo um núcleo beteroaromático anel-benzilo-amida-ciclo |
| CN108299411B (zh) * | 2017-01-13 | 2021-02-05 | 中国人民解放军军事医学科学院毒物药物研究所 | 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途 |
| US12221463B2 (en) | 2020-08-07 | 2025-02-11 | The Board Of Regents Of The University Of Oklahoma | Method of promoting wound healing by inhibiting CCR3 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2139084C3 (de) | 1971-08-04 | 1979-03-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen |
| IL90858A (en) | 1988-07-07 | 1994-08-26 | Rhone Poulenc Sante | Derivatives of (AZA) naphthalensultam, their preparation and compositions containing them |
| US5352684A (en) | 1990-04-10 | 1994-10-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyridines as medicaments |
| DE4140542A1 (de) | 1991-12-09 | 1993-06-17 | Bayer Ag | Piperdylmethyl substituierte chormanderivate |
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| DE19756235A1 (de) * | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide |
| HN1999000149A (es) * | 1998-09-09 | 2000-01-12 | Pfizer Prod Inc | Derivados de 4,4-biarilpiperidina |
| US6046331A (en) | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
-
1999
- 1999-07-21 SE SE9902765A patent/SE9902765D0/xx unknown
-
2000
- 2000-07-18 IL IL14714900A patent/IL147149A0/xx unknown
- 2000-07-18 DE DE60001586T patent/DE60001586T2/de not_active Expired - Fee Related
- 2000-07-18 NZ NZ516606A patent/NZ516606A/en unknown
- 2000-07-18 KR KR1020027000797A patent/KR20020027498A/ko not_active Ceased
- 2000-07-18 EP EP00946134A patent/EP1202984B1/en not_active Expired - Lifetime
- 2000-07-18 JP JP2001511441A patent/JP2003505383A/ja not_active Withdrawn
- 2000-07-18 WO PCT/GB2000/002756 patent/WO2001005782A1/en not_active Ceased
- 2000-07-18 MX MXPA02000671A patent/MXPA02000671A/es active IP Right Grant
- 2000-07-18 CA CA002378084A patent/CA2378084A1/en not_active Abandoned
- 2000-07-18 CN CNB008106703A patent/CN1152873C/zh not_active Expired - Fee Related
- 2000-07-18 AU AU60016/00A patent/AU771344B2/en not_active Ceased
- 2000-07-18 BR BR0012610-1A patent/BR0012610A/pt not_active IP Right Cessation
- 2000-07-18 US US09/623,744 patent/US6566376B1/en not_active Expired - Fee Related
- 2000-07-18 AT AT00946134T patent/ATE233754T1/de not_active IP Right Cessation
-
2001
- 2001-12-21 ZA ZA200110540A patent/ZA200110540B/xx unknown
-
2002
- 2002-01-18 NO NO20020282A patent/NO20020282L/no unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531835A (ja) * | 2007-07-02 | 2010-09-30 | エフ.ホフマン−ラ ロシュ アーゲー | Ccr2受容体アンタゴニストとしてのイミダゾール誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2378084A1 (en) | 2001-01-25 |
| AU6001600A (en) | 2001-02-05 |
| EP1202984B1 (en) | 2003-03-05 |
| CN1361775A (zh) | 2002-07-31 |
| SE9902765D0 (sv) | 1999-07-21 |
| IL147149A0 (en) | 2002-08-14 |
| US6566376B1 (en) | 2003-05-20 |
| ZA200110540B (en) | 2003-03-24 |
| KR20020027498A (ko) | 2002-04-13 |
| CN1152873C (zh) | 2004-06-09 |
| MXPA02000671A (es) | 2002-07-02 |
| NO20020282L (no) | 2002-03-21 |
| NZ516606A (en) | 2003-09-26 |
| AU771344B2 (en) | 2004-03-18 |
| NO20020282D0 (no) | 2002-01-18 |
| DE60001586D1 (de) | 2003-04-10 |
| ATE233754T1 (de) | 2003-03-15 |
| EP1202984A1 (en) | 2002-05-08 |
| DE60001586T2 (de) | 2004-02-12 |
| BR0012610A (pt) | 2002-04-09 |
| WO2001005782A1 (en) | 2001-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6566376B1 (en) | Diphenyl-piperidine derivative | |
| US7238688B2 (en) | Piperidine compounds | |
| US20040006081A1 (en) | Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity | |
| JP2003507456A (ja) | ケモカインレセプター活性のモジュレーターとして有用な置換ピペリジン化合物 | |
| KR20050052511A (ko) | 케모킨 매개된 질병 상태의 치료에서 사용하기 위한 신규피페리딘 유도체 | |
| KR20010108394A (ko) | 신규 화합물 | |
| JP4459622B2 (ja) | ピペリジン誘導体およびケモカイン・レセプター(特にccr5)活性モジュレーターとしてのその使用 | |
| JP2005511621A (ja) | ケモカインレセプターの調節物質としての新規ピペリジン誘導体 | |
| JP2005526797A (ja) | ケモカイン受容体活性(特にccr5)のモジュレーターとして有用なピペリジンまたは8−アザ−ビシクロ[3.2.1]オクタ−3−イル誘導体 | |
| EP1363902B1 (en) | Chemical compounds | |
| JP2005513017A (ja) | ケモカイン受容体(特にccr)活性のモジュレーターとしてのピペリジン誘導体とその使用 | |
| JP2004520423A (ja) | Ccr5モジュレーターとしてのn−ピペリジニル化合物 | |
| US6562825B1 (en) | Piperazine derivatives as modulators of chemokine receptor activity | |
| JP2005501869A (ja) | ケモカインレセプター活性の調節物質としての新規なピペリジニル−モルホリニル誘導体 | |
| US20090030039A1 (en) | Piperidine Derivatives as Cxcr3 Receptor Antagonists | |
| JP2005501866A (ja) | ケモカイン受容体活性のモジュレーターとしての新規ピペリジニル誘導体 | |
| EP2200982B1 (en) | Piperidine derivatives as nk3 receptor antagonists | |
| JP2007528867A (ja) | ケモカイン受容体活性のモジュレーターとして有用なピペリジンもしくは8−アザ−ビシクロ[3.2.1]オクタ−3−イル誘導体 | |
| WO2003087063A1 (en) | Imidazolidine compounds as chemokine receptor modulators | |
| CN101124203A (zh) | 化合物 | |
| JPWO2005030722A1 (ja) | N−置換−n−(4−ピペリジニル)アミド誘導体 | |
| JP2007500694A (ja) | Ccr5受容体モジュレーターとしてのピペリジン誘導体 | |
| JP2009526016A (ja) | Cxcr3受容体拮抗物質としてのピペリジン誘導体 | |
| WO2004032856A2 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070620 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070620 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20080501 |